Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as Control
NCT00697866
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
951
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Interventions
BIOLOGICAL:
HBV-MPL vaccine 208129
BIOLOGICAL:
Engerix™-B
Sponsor
GlaxoSmithKline